NanoViricides

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue
$0
$0
$0
$0
Gross Profit
-189
-189
-189
EBITDA
-1,718
-1,995
-1,743
EBIT
-1,908
-2,184
-1,932
-3,676
Net Income
-1,854
-2,114
-1,968
-3,569
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,988
-1,724
-1,179
-1,501
Cash
3,257
5,245
6,969
8,149
Basic Shares
11,779
11,745
11,718
11,698

Annual Financials

Values in thousands 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Revenue
$0
$0
$0
$0
Gross Profit
-747
-723
-704
-699
EBITDA
-7,840
-7,378
-8,030
-7,422
EBIT
-8,587
-8,101
-8,734
-8,122
Net Income
-8,588
-8,100
-8,907
-13,397
Net Change In Cash
0
0
0
0
Cost of Revenue
11,153
Free Cash Flow
-5,821
-6,215
-8,452
-6,674
Cash
8,149
14,066
20,516
13,708
Basic Shares
11,626
11,534
10,900
5,616

Earnings Calls

Quarter EPS
2024-03-31
-$0.16
2023-12-31
-$0.18
2023-09-30
-$0.15
2023-06-30
-$0.30